Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


Anemia and iron deficiency in gastrointestinal and liver conditions.

Stein J, Connor S, Virgin G, Ong DE, Pereyra L.

World J Gastroenterol. 2016 Sep 21;22(35):7908-25. doi: 10.3748/wjg.v22.i35.7908. Review.


Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case-Control Cohort Study.

Chou CI, Shih CJ, Chen YT, Ou SM, Yang CY, Kuo SC, Chu D.

Medicine (Baltimore). 2016 Mar;95(9):e2645. doi: 10.1097/MD.0000000000002645.


Is pathology necessary to predict mortality among men with prostate-cancer?

Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Baniel J, Fleshner N, Austin PC.

BMC Med Inform Decis Mak. 2014 Dec 12;14:114. doi: 10.1186/s12911-014-0114-6.


Medicinal cannabis: time to lighten up?

Juurlink DN.

CMAJ. 2014 Sep 2;186(12):897-8. doi: 10.1503/cmaj.140309. Epub 2014 Jun 23. No abstract available.


Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).

Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project.

Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. Review.


Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.

O'Neil CK, Hanlon JT, Marcum ZA.

Am J Geriatr Pharmacother. 2012 Dec;10(6):331-42. doi: 10.1016/j.amjopharm.2012.09.004. Epub 2012 Oct 2. Review.


A study of the changes in the cause of peptic ulcer bleeding.

Fujinami H, Kudo T, Hosokawsa A, Ogawa K, Miyazaki T, Nishikawa J, Kajiura S, Ando T, Ueda A, Sugiyama T.

World J Gastrointest Endosc. 2012 Jul 16;4(7):323-7. doi: 10.4253/wjge.v4.i7.323.


Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature.

Taylor R Jr, Raffa RB, Pergolizzi JV Jr.

J Pain Res. 2012;5:77-87. doi: 10.2147/JPR.S21965. Epub 2012 Apr 23.


Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation.

Graham DY, Jewell NP, Chan FK.

Am J Med Sci. 2011 Nov;342(5):356-64. doi: 10.1097/MAJ.0b013e3182113658.


Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients.

Luo R, Liu G, Liu W, Pei F, Zhou Z, Li J, Shen B, Kang P, Xie Q, Ma X.

Int Orthop. 2011 Sep;35(9):1409-14. doi: 10.1007/s00264-010-1062-0. Epub 2010 Jun 13.


Celecoxib in arthritis: relative risk management profile and implications for patients.

McKellar G, Singh G.

Ther Clin Risk Manag. 2009;5:889-96. Epub 2009 Nov 18.


Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario.

Raina PS, Gafni A, Bell S, Grant S, Sebaldt RJ, Fan A, Petrie A, Skilton K.

Healthc Policy. 2007 Nov;3(2):e128-44.


New horizons and perspectives in the treatment of osteoarthritis.

Berenbaum F.

Arthritis Res Ther. 2008;10 Suppl 2:S1. doi: 10.1186/ar2462. Epub 2008 Oct 17. Review.


An economic model of long-term use of celecoxib in patients with osteoarthritis.

Loyd M, Rublee D, Jacobs P.

BMC Gastroenterol. 2007 Jul 4;7:25.


Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario.

Mamdani M, Warren L, Kopp A, Paterson JM, Laupacis A, Bassett K, Anderson GM.

CMAJ. 2006 Dec 5;175(12):1535-8.

Supplemental Content

Support Center